Annual report pursuant to Section 13 and 15(d)

SELECTED FINANCIAL STATEMENT LIABILITIES (Tables)

v3.22.1
SELECTED FINANCIAL STATEMENT LIABILITIES (Tables)
12 Months Ended
Dec. 31, 2021
Payables And Accruals [Abstract]  
Schedule of accounts payable and accrued expenses

Accounts payable and accrued expenses consisted of the following (in thousands):

 

 

 

December 31, 2021

 

 

December 31, 2020

 

Accounts payable:

 

 

 

 

 

 

 

 

Clinical and regulatory expenses

 

$

534

 

 

$

262

 

Professional fees

 

 

477

 

 

 

252

 

Selling expenses

 

 

932

 

 

 

395

 

Manufacturing cost

 

 

378

 

 

 

596

 

Other vendors

 

 

262

 

 

 

518

 

Total accounts payable

 

 

2,583

 

 

 

2,023

 

Accrued interest payable, related parties

 

91

 

 

 

41

 

Accrued interest payable

 

 

579

 

 

 

627

 

Accrued expenses:

 

 

 

 

 

 

 

 

Payroll expenses

 

 

1,097

 

 

 

1,053

 

Government rebates and other rebates

 

 

4,371

 

 

 

2,659

 

Due to equity method investee

 

 

 

 

 

545

 

Other accrued expenses

 

 

468

 

 

 

512

 

Total accrued expenses

 

 

5,936

 

 

 

4,769

 

Total accounts payable and accrued expenses

 

$

9,189

 

 

$

7,460

 

Schedule of other current liabilities

Other current liabilities consisted of the following (in thousands):

 

 

As of December 31,

 

 

2021

 

 

2020

 

Trade discount

$

3,000

 

 

$

2,000

 

Other current liabilities

 

1,404

 

 

 

699

 

Total other current liabilities

$

4,404

 

 

$

2,699

 

Schedule of other long-term liabilities

Other long-term liabilities consisted of the following (in thousands):

 

 

As of December 31,

 

 

2021

 

 

2020

 

Trade discount

$

23,148

 

 

$

24,453

 

Unearned revenue

 

10,000

 

 

 

10,000

 

Other long-term liabilities

 

25

 

 

 

17

 

Total other long-term liabilities

$

33,173

 

 

$

34,470